About lab
The paper describes a model on the key components for tumor–immune dynamics in multiple myeloma. Created by COPASI 4.25 (Build 207) This model is described in the article: The Role of the Innate Immun.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagephan2017-innate-immune-in-oncolytic-virotherapy-lab
Created2026-05-15
Updated2026-05-15
immunologysbmlbiomodels_ebifaithfulcuratedvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "initial_unresolved_tumor_observable_1",
"label": "Initial Unresolved Tumor Observable 1",
"units": "substance",
"default": 0.99,
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.initial_unresolved_tumor_observable_1",
"description": "Initial Unresolved Tumor Observable 1. Sets the initial value of bundled SBML species `x`."
},
{
"name": "initial_unresolved_tumor_observable_2",
"label": "Initial Unresolved Tumor Observable 2",
"units": "substance",
"default": 0.01,
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.initial_unresolved_tumor_observable_2",
"description": "Initial Unresolved Tumor Observable 2. Sets the initial value of bundled SBML species `y`."
},
{
"name": "initial_unresolved_tumor_observable_3",
"label": "Initial Unresolved Tumor Observable 3",
"units": "substance",
"default": 0.01,
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.initial_unresolved_tumor_observable_3",
"description": "Initial Unresolved Tumor Observable 3. Sets the initial value of bundled SBML species `v`."
},
{
"name": "initial_unresolved_tumor_observable_4",
"label": "Initial Unresolved Tumor Observable 4",
"units": "substance",
"default": 0.01,
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.initial_unresolved_tumor_observable_4",
"description": "Initial Unresolved Tumor Observable 4. Sets the initial value of bundled SBML species `z`."
},
{
"name": "infected_tumor_killing_rate",
"label": "Infected Tumor Killing Rate",
"units": "unit_0",
"default": 0.48,
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.infected_tumor_killing_rate",
"description": "Infected Tumor Killing Rate. Sets bundled SBML parameter `c`."
},
{
"name": "virus_killing_by_immune_rate",
"label": "Virus Killing By Immune Rate",
"units": "unit_0",
"default": 0.16,
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.virus_killing_by_immune_rate",
"description": "Virus Killing By Immune Rate. Sets bundled SBML parameter `d`."
}
],
"outputs": [
{
"name": "unresolved_tumor_observable_1",
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.unresolved_tumor_observable_1"
},
{
"name": "unresolved_tumor_observable_2",
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.unresolved_tumor_observable_2"
},
{
"name": "unresolved_tumor_observable_3",
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.unresolved_tumor_observable_3"
},
{
"name": "unresolved_tumor_observable_4",
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.unresolved_tumor_observable_4"
},
{
"name": "state",
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.state"
},
{
"name": "summary",
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.summary"
},
{
"name": "species_labels",
"maps_to": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.species_labels"
}
]
},
"title": "Phan2017 - innate immune in oncolytic virotherapy Lab",
"models": [
{
"path": "owned/models/immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model",
"alias": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model",
"provenance": {
"owned_path": "owned/models/immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model_state"
],
"from": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.state"
},
{
"to": [
"visualisation.immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model_summary"
],
"from": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.summary"
},
{
"to": [
"visualisation.immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model_species_labels"
],
"from": "immunology_sbml_phan2017_innate_immune_in_oncolytic_virotherapy_biomd0000000748_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "The paper describes a model on the key components for tumor–immune dynamics in multiple myeloma. Created by COPASI 4.25 (Build 207) This model is described in the article: The Role of the Innate Immun.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.